[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

2019 Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ...

April 2019 55 pages

2019 Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ...

April 2019 55 pages

2019 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ...

April 2019 51 pages

2019 Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ...

April 2019 46 pages

2019 Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucopolysaccharidosis VI (MPS VI) (Maroteaux ...

April 2019 41 pages

2019 Mucositis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Mucositis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mucositis. It presents in-depth analysis of Mucositis clinical trials across markets and companies ...

April 2019 184 pages

2019 Mumps Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Mumps Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mumps. It presents in-depth analysis of Mumps clinical trials across markets and companies ...

April 2019 65 pages

2019 Muscle Atrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscle Atrophy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Atrophy. It presents in-depth analysis of Muscle Atrophy clinical trials across markets and companies ...

April 2019 185 pages

2019 Muscle Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscle Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Injury. It presents in-depth analysis of Muscle Injury clinical trials across markets and companies ...

April 2019 105 pages

2019 Muscle Invasive Bladder Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Muscle Invasive Bladder Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Invasive Bladder Cancer. It presents in-depth analysis of Muscle Invasive Bladder Cancer clinical trials ...

April 2019 105 pages

2019 Muscle Relaxation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscle Relaxation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Relaxation. It presents in-depth analysis of Muscle Relaxation clinical trials across markets and companies ...

April 2019 81 pages

2019 Muscle Spasm Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscle Spasm Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Spasm. It presents in-depth analysis of Muscle Spasm clinical trials across markets and companies ...

April 2019 171 pages

2019 Muscle Spasticity Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscle Spasticity Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Spasticity. It presents in-depth analysis of Muscle Spasticity clinical trials across markets and companies ...

April 2019 210 pages

2019 Muscle Wasting Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscle Wasting Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Wasting Disorders. It presents in-depth analysis of Muscle Wasting Disorders clinical trials ...

April 2019 182 pages

2019 Muscular Dystrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Muscular Dystrophy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscular Dystrophy. It presents in-depth analysis of Muscular Dystrophy clinical trials across markets and companies ...

April 2019 197 pages

2019 Myalgia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myalgia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myalgia. It presents in-depth analysis of Myalgia clinical trials across markets and companies ...

April 2019 122 pages

2019 Myasthenia Gravis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myasthenia Gravis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myasthenia Gravis. It presents in-depth analysis of Myasthenia Gravis clinical trials across markets and companies ...

April 2019 66 pages

2019 Mycobacterium avium Intracellulare Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Mycobacterium avium Intracellulare Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycobacterium avium Intracellulare Infections. It presents in-depth analysis of Mycobacterium avium Intracellulare Infections clinical trials ...

April 2019 44 pages

2019 Mycoplasma pneumoniae Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Mycoplasma pneumoniae Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycoplasma pneumoniae Infections. It presents in-depth analysis of Mycoplasma pneumoniae Infections clinical trials ...

April 2019 42 pages

2019 Mycosis Fungoides Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Mycosis Fungoides Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycosis Fungoides. It presents in-depth analysis of Mycosis Fungoides clinical trials across markets and companies ...

April 2019 141 pages

2019 Myelofibrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myelofibrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myelofibrosis. It presents in-depth analysis of Myelofibrosis clinical trials across markets and companies ...

April 2019 238 pages

2019 Myeloid Metaplasia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myeloid Metaplasia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myeloid Metaplasia. It presents in-depth analysis of Myeloid Metaplasia clinical trials across markets and companies ...

April 2019 227 pages

2019 Myelopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myelopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myelopathy. It presents in-depth analysis of Myelopathy clinical trials across markets and companies ...

April 2019 65 pages

2019 Myocardial Ischemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myocardial Ischemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myocardial Ischemia. It presents in-depth analysis of Myocardial Ischemia clinical trials across markets and companies ...

April 2019 310 pages

2019 Myoclonic Seizure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myoclonic Seizure Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myoclonic Seizure. It presents in-depth analysis of Myoclonic Seizure clinical trials across markets and companies ...

April 2019 120 pages

2019 Myopia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myopia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myopia. It presents in-depth analysis of Myopia clinical trials across markets and companies ...

April 2019 130 pages

2019 Myxoid Liposarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Myxoid Liposarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myxoid Liposarcoma. It presents in-depth analysis of Myxoid Liposarcoma clinical trials across markets and companies ...

April 2019 49 pages

2019 Narcolepsy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Narcolepsy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Narcolepsy. It presents in-depth analysis of Narcolepsy clinical trials across markets and companies ...

April 2019 70 pages

2019 Nasal Congestion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nasal Congestion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Congestion. It presents in-depth analysis of Nasal Congestion clinical trials across markets and companies ...

April 2019 62 pages

2019 Nasal Obstruction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nasal Obstruction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Obstruction. It presents in-depth analysis of Nasal Obstruction clinical trials across markets and companies ...

April 2019 56 pages

2019 Nasal Polyposis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nasal Polyposis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Polyposis. It presents in-depth analysis of Nasal Polyposis clinical trials across markets and companies ...

April 2019 113 pages

2019 Nasal Polyps Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nasal Polyps Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasal Polyps. It presents in-depth analysis of Nasal Polyps clinical trials across markets and companies ...

April 2019 110 pages

2019 Nasopharyngeal Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nasopharyngeal Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nasopharyngeal Cancer. It presents in-depth analysis of Nasopharyngeal Cancer clinical trials across markets and companies ...

April 2019 272 pages

2019 Natural Killer Cell Lymphomas Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Natural Killer Cell Lymphomas Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Natural Killer Cell Lymphomas. It presents in-depth analysis of Natural Killer Cell Lymphomas clinical trials ...

April 2019 112 pages

2019 Neck Pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neck Pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neck Pain. It presents in-depth analysis of Neck Pain clinical trials across markets and companies ...

April 2019 100 pages

2019 Neisseria meningitidis Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neisseria meningitidis Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neisseria meningitidis Infections. It presents in-depth analysis of Neisseria meningitidis Infections clinical trials ...

April 2019 292 pages

2019 Neonatal Respiratory Distress Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Neonatal Respiratory Distress Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neonatal Respiratory Distress Syndrome. It presents in-depth analysis of Neonatal Respiratory Distress Syndrome clinical trials ...

April 2019 115 pages

2019 Neonatal Seizures Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neonatal Seizures Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neonatal Seizures. It presents in-depth analysis of Neonatal Seizures clinical trials across markets and companies ...

April 2019 47 pages

2019 Neoplastic Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neoplastic Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neoplastic Syndrome. It presents in-depth analysis of Neoplastic Syndrome clinical trials across markets and companies ...

April 2019 54 pages

2019 Neovascular Glaucoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neovascular Glaucoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neovascular Glaucoma. It presents in-depth analysis of Neovascular Glaucoma clinical trials across markets and companies ...

April 2019 48 pages

2019 Nephrotic Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nephrotic Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nephrotic Syndrome. It presents in-depth analysis of Nephrotic Syndrome clinical trials across markets and companies ...

April 2019 102 pages

2019 Neuroblastoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neuroblastoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuroblastoma. It presents in-depth analysis of Neuroblastoma clinical trials across markets and companies ...

April 2019 238 pages

2019 Neuroendocrine Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neuroendocrine Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuroendocrine Carcinoma. It presents in-depth analysis of Neuroendocrine Carcinoma clinical trials across markets and companies ...

April 2019 159 pages

2019 Neurofibromatoses Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neurofibromatoses Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurofibromatoses. It presents in-depth analysis of Neurofibromatoses clinical trials across markets and companies ...

April 2019 159 pages

2019 Neurofibromatoses Type I (Von Recklinghausen’s Disease) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Neurofibromatoses Type I (Von Recklinghausen’s Disease) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurofibromatoses Type I (Von Recklinghausen’s Disease ...

April 2019 118 pages

2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuromyelitis Optica (Devic’s Syndrome). It presents in-depth analysis of Neuromyelitis Optica (Devic’s Syndrome) clinical trials ...

April 2019 60 pages

2019 Neurotoxicity Syndromes Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neurotoxicity Syndromes Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurotoxicity Syndromes. It presents in-depth analysis of Neurotoxicity Syndromes clinical trials across markets and companies ...

April 2019 116 pages

2019 Neutropenia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neutropenia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neutropenia. It presents in-depth analysis of Neutropenia clinical trials across markets and companies ...

April 2019 219 pages

2019 Nicotine Addiction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nicotine Addiction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nicotine Addiction. It presents in-depth analysis of Nicotine Addiction clinical trials across markets and companies ...

April 2019 243 pages

2019 Nocturia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nocturia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturia. It presents in-depth analysis of Nocturia clinical trials across markets and companies ...

April 2019 81 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers